Which year and place the figures cover
UKHSA's latest annual STI report, published on 2 June 2026, reports calendar-year 2025 diagnoses among England residents accessing sexual-health services. Its comparison year is 2024. The word UK in this guide's title describes the reader and service context; the counts below must never be treated as totals for Scotland, Wales or Northern Ireland. The report also includes chlamydia screening data, but this page focuses on two bacterial infections. UKHSA's surveillance is a measure of recorded diagnoses, not a census of everyone living with an infection.
A diagnosis is a clinical event. Someone with no symptoms may be found through screening; someone who does not attend a service may not appear in these data. UKHSA uses routine GUMCAD returns and explains adjustments and limitations in its methods. For individual decisions, the testing and partner-notification guide is more useful than extrapolating from a national average. The sexual-health glossary and clinic glossary explain the broader context.
Gonorrhoea decreased in 2025
The annual report records 63,943 gonorrhoea diagnoses in England in 2025, down from 71,766 in 2024: a 10.9% decline. This is a change in recorded diagnoses between two years, not proof that exposure has become safe. The report says all new STI diagnoses fell from 364,261 to 334,151, an 8.3% decrease. Gonorrhoea still represented 19.1% of recorded new STI diagnoses in 2025. A single person can make decisions about testing and barriers without guessing their probability from that percentage.
The report's subgroup figures tell a more specific story: among gay, bisexual and other men who have sex with men attending services, diagnoses declined 5.9%, from 39,156 to 36,833. These are service-based categories and do not label any individual's behaviour or result. Trends can differ by geography and population. The NHS gonorrhoea page describes symptoms, testing and treatment; infections can occur without obvious symptoms and may involve different anatomical sites.
Infectious syphilis also decreased
UKHSA records 8,262 diagnoses of infectious syphilis in England in 2025, down from 9,553 in 2024, a 13.5% decrease. Here infectious syphilis includes primary, secondary and early latent stages; it is not the same as a count of every stage of syphilis. Among gay, bisexual and other men who have sex with men, the report records 5,164 diagnoses, down from 6,349, an 18.7% decrease. Its breakdown also records a small increase among heterosexual and bisexual women who have sex with men, from 838 to 878; a national decrease can coexist with different subgroup patterns.
The NHS syphilis page explains that symptoms may be easy to miss and that a blood test can be part of assessment. A sore or rash needs a clinician's assessment rather than an image search, because other conditions can look similar. Syphilis in pregnancy has consequences that make antenatal screening and prompt follow-up important. A falling annual count does not tell someone with a possible exposure to wait until the next data release before seeking advice.
Why a fall does not settle your risk
UKHSA reports changes in clinic testing and service attendance alongside diagnoses. A lower count may reflect changing infection patterns, but testing access, who presents, and data completeness also matter when interpreting a trend. The report explicitly notes disrupted services in 2020 and 2021; those years are a poor simple baseline for a current comparison. England figures cannot be applied mechanically to all four UK nations. The 2025 report is a snapshot published in 2026, and later provisional quarterly data may change before another full annual series appears.
Personal exposure depends on contact, barriers, vaccination where relevant, partners and timing; it cannot be calculated from a population headline. Oral contact can also matter, and a urine sample alone may not cover a throat or rectal site. A clinic can decide which specimens and windows are relevant. If a partner has a diagnosis, tell the service even if you feel well. The prevention guide sets out barriers and testing without claiming any one measure eliminates risk.
Resistance and appropriate treatment
UKHSA actively monitors gonorrhoea resistant to ceftriaxone, which it describes as the current first-line therapy in its report. The existence of resistance is a reason for surveillance and clinical follow-up, not a reason for a reader to choose an antibiotic or request a particular regimen. UKHSA's GRASP programme tracks antimicrobial resistance. Do not buy or share treatment on the basis of a headline or assume a previous prescription is suitable now. A clinician can arrange testing and any required follow-up.
Partner notification can interrupt further transmission. NHS clinic guidance says staff can help contact partners and usually do so without identifying the person who supplied their details. The time span and action differ by infection and clinical history; ask the service rather than inventing a rule. If contact feels unsafe, discuss confidential assistance privately. Treatment and notification are health matters, not evidence of a person's character or a reason for public disclosure.
Choose a test for the exposure
The NHS STI overview says many infections cause no symptoms. Tell a clinic about the type and timing of contact, symptoms and any known partner diagnosis. It can advise on blood tests and swabs from relevant sites, including a throat or rectum when appropriate. If a self-sampling kit has only a urine sample, ask what it does and does not cover. Different infections and tests have different window periods; an early negative may need repeating according to service advice. A positive result requires specific treatment and partner advice.
Do not defer a symptom assessment until an arbitrary window ends. A sore, discharge, pain, bleeding or rash may have several causes, and a clinician can assess those alongside testing. Possible recent HIV exposure raises a separate urgent PEP question; the PrEP and PEP guide explains that route. Condoms and dams reduce risk when used correctly, but no population statistic replaces a discussion of what protection each partner accepts. The barriers glossary provides a starting point.
Common questions about the trends
Are these figures for the whole UK? No: they are 2025 England sexual-health-service data. Did gonorrhoea disappear? No; 63,943 diagnoses were recorded. Is the syphilis figure every case or stage? No; the 8,262 figure is infectious syphilis as UKHSA defines it. Does a falling count mean a negative test is unnecessary? No. Could a person have an infection without symptoms? Yes. Can one urine test answer every question? No; body site and infection matter. Does a positive result identify which partner transmitted it? The result alone cannot establish that.
What if my exposure was in Scotland, Wales or Northern Ireland? Seek the local service; do not treat England counts as your nation's rate. What if a partner has been diagnosed? Tell the clinic the infection and timing and ask about assessment and notification. What if a mail-order result is unclear? Contact the testing service for interpretation, rather than treating it as a final answer. Why do news headlines differ? Check whether they compare calendar years, provisional quarters, rates, total diagnoses or one subgroup.
UK routes for syphilis and gonorrhoea
In England, the NHS clinic finder can locate testing; NHS inform directs Scottish services, NHS 111 Wales lists Welsh clinics, and Sexual Health NI lists Northern Ireland GUM clinics. Give the service the infection and timing if a partner was diagnosed. Ask about the right samples, treatment and confidential notification; access to home kits differs by area.
A sexual-health clinic can explain a test window, choose body sites, treat a confirmed infection and help notify partners confidentially. Ask a GP about persistent symptoms or a possible non-STI cause. In an urgent situation, use the appropriate local urgent-care route; a recent possible HIV exposure needs prompt PEP assessment. The UK help directory links to services. This page records a particular annual release; consult the linked UKHSA statistics page for subsequent releases rather than assuming these numbers stay current.